Are Analysts Expecting A Better 2020 For Allogene Therapeutics Inc (ALLO)?
Allogene Therapeutics Inc (ALLO) concluded trading on Wednesday at a closing price of $1.66, with 7.01 million shares of worth about $11.64 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.78% during that period and on July 23, 2025 the price saw a […]
Technical Outlook And Game Plan For Allogene Therapeutics Inc (NASDAQ: ALLO)
Allogene Therapeutics Inc (ALLO) concluded trading on Wednesday at a closing price of $1.21, with 9.59 million shares of worth about $11.6 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -43.98% during that period and on July 09, 2025 the price saw a […]
Is There More Upside Ahead For Allogene Therapeutics Inc (NASDAQ: ALLO)
Allogene Therapeutics Inc (ALLO) concluded trading on Wednesday at a closing price of $1.2, with 4.81 million shares of worth about $5.77 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -45.21% during that period and on July 02, 2025 the price saw a […]
Is There More Upside Ahead For Allogene Therapeutics Inc (NASDAQ: ALLO)
Allogene Therapeutics Inc (ALLO) concluded trading on Wednesday at a closing price of $4.15, with 4.08 million shares of worth about $16.92 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -6.95% during that period and on Wednesday February 7 the price saw a […]
Analyst Expect Big Moves From Allogene Therapeutics Inc (NASDAQ: ALLO)
Fidelity Management & Research Co recently announced the acquisition of new stake in Allogene Therapeutics Inc (NASDAQ:ALLO). The institutional investor has increased its shareholding in the Healthcare company by 0.91% to 25.14 million shares with purchase of 0.23 million shares. This fresh investment now brings its stake to 14.94% valued currently at $59.09 million. In […]
Allogene Therapeutics Inc (NASDAQ: ALLO): Hunting Genuine Value In Market Debris
Fidelity Management & Research Co recently announced the acquisition of new stake in Allogene Therapeutics Inc (NASDAQ:ALLO). The institutional investor has increased its shareholding in the Healthcare company by 0.91% to 25.14 million shares with purchase of 0.23 million shares. This fresh investment now brings its stake to 14.94% valued currently at $59.09 million. In […]